Post-IPO Equity - GlucoTrack
Investment Firm
Overview
GlucoTrack is a medical device manufacturing company that specializes in developing a non-invasive glucose monitoring devices.
Announced Date
Jul 31, 2024
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
 John Ballantyne |
Round Details and Background
GlucoTrack raised $4000000 on 2024-07-31 in Post-IPO Equity
GlucoTrack is a medical device manufacturing company that specializes in developing a non-invasive glucose monitoring devices.
Company Funding History
10
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 03, 2014 |  Post-IPO Equity - GlucoTrack | - | 3.0M | |
| Dec 27, 2010 | Venture Round - GlucoTrack | - | 3.6M | |
| Mar 24, 2010 | Debt Financing - GlucoTrack | - | 50.0K | |
| Mar 28, 2013 | Post-IPO Equity - GlucoTrack | - | 7.5M |
Recent Activity
There is no recent news or activity for this profile.